v3.24.0.1
Intangible Assets, Net
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net Intangible Assets, Net
The following tables present details of our intangible assets, net:
December 31, 2023
(dollars in thousands)Useful Life
(in years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Weighted Average Remaining Useful Life
(in years)
Customer relationships
 9-13
$75,500 $(19,223)$56,277 8.7
Developed technology
1-5
56,298 (53,157)3,141 2.8
Trademarks
1-9
12,716 (12,159)557 5.3
Content library39,500 (8,577)923 0.3
$154,014 $(93,116)$60,898 8.2
December 31, 2022
(dollars in thousands)Useful Life
(in years)		Gross
Carrying
Amount		Accumulated
Amortization 		Net
Carrying
Amount		Weighted Average Remaining Useful Life
(in years)
Customer relationships
9-13
$96,600 $(14,151)$82,449 9.8
Developed technology
1-5
86,298 (54,483)31,815 4.0
Trademarks
1-9
14,352 (12,841)1,511 3.9
Content library39,500 (5,410)4,090 1.3
Backlog11,900 (1,900)— 0.0
$208,650 $(88,785)$119,865 7.9
For the years ended December 31, 2023, 2022 and 2021, amortization expense was $59.0 million, $23.2 million and $18.3 million, respectively. Amortization of intangible assets acquired in connection with vitaCare was accelerated during the year ended December 31, 2023 as we de-prioritized certain solutions under our pharma manufacturer solutions platform for which these intangible assets supported and were disposed of as of December 31, 2023. See "Note 17. Restructuring Plan."
At December 31, 2023, the expected amortization of intangible assets, net for future periods was as follows:
(in thousands)
Year Ending December 31,
2024$8,796 
20257,838 
20267,518 
20276,739 
20286,698 
Thereafter23,309 
$60,898